Announcements Trials
Browse Landscape

Phase

Phase NA 68Phase 2 33Phase 3 25Phase 4 7Phase 2/3 4Phase 1 4Phase 1/2 2Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Breast Neoplasms 161Neoplasms 95Prostatic Neoplasms 86Glioblastoma 76Multiple Myeloma 65Pancreatic Neoplasms 63Glioma 61Brain Neoplasms 56Lung Neoplasms 46Carcinoma, Hepatocellular 44Melanoma 43Head and Neck Neoplasms 43Recurrence 41Carcinoma, Non-Small-Cell Lung 41Leukemia, Myeloid, Acute 40Colorectal Neoplasms 38Squamous Cell Carcinoma of Head and Neck 35Ovarian Neoplasms 35Precursor Cell Lymphoblastic Leukemia-Lymphoma 31Neoplasm Metastasis 29Lymphoma, Non-Hodgkin 29Lymphoma 28Carcinoma, Renal Cell 28Polycystic Ovary Syndrome 27Stomach Neoplasms 24Hematologic Neoplasms 23Lymphoma, B-Cell 22Sarcoma 21Endometrial Neoplasms 20Uterine Cervical Neoplasms 19

Interventions

Ondansetron 1Dexamethasone 1Aprepitant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × OTHER × Nausea × Clear all
NCT00314743 2013-05-24

Efficacy & Safety of the Oral Neurokinin-1 Antagonist, Aprepitant, in Combo With Ondansetron & Dexamethasone in Patients Undergoing Auto Peripheral Blood Stem Cell Transplantation

Washington University School of Medicine

Phase EARLY_PHASE1 Completed
48 enrolled
Plasma cell

Multiple Myeloma, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡